
Gates Open Research, Journal Year: 2024, Volume and Issue: 8, P. 94 - 94
Published: Oct. 21, 2024
Language: Английский
Gates Open Research, Journal Year: 2024, Volume and Issue: 8, P. 94 - 94
Published: Oct. 21, 2024
Language: Английский
Health Science Reports, Journal Year: 2025, Volume and Issue: 8(1)
Published: Jan. 1, 2025
ABSTRACT Background and Aims The recently approved maternal vaccination against respiratory syncytial virus (RSV) can reduce its burden among infants. However, vaccine hesitancy/resistance undermine the beneficial impact of RSV vaccination. aim this study was to assess willingness pregnant women in Jordan receive associated determinants. Methods Face‐to‐face interviews were conducted obstetrics/gynecology clinics Central, Northern, Southern regions during January–February 2024, using a convenience sampling approach. Attitude assessed previously validated ABCDEF scale. Results A total 404 participated with mean age 30.1 ± 6.2 years. majority participants showed ( n = 313, 77.5%), hesitancy 25 (6.2%), resistance 66 (16.3%). Variables that significantly higher acceptance multivariate analysis were: < 30 years (adjusted odds ratio (aOR): 2.45, p 0.010), undergraduates (aOR: 3.27, 0.026), being healthcare worker 4.50, 0.036), history previous COVID‐19/influenza uptake 2.47, 0.045). Two out six constructs acceptance, namely “Advice” construct 10.38, 0.001) “Fear” 21.49, 0.001). Conclusion This highlighted complex nature attitude towards women. role demographic variables, prior experience, trust credible health institutions safety, fear disease consequences infants shaping Addressing these factors help effectively promote women, subsequently helping protect from significant burden.
Language: Английский
Citations
1Vaccines, Journal Year: 2025, Volume and Issue: 13(2), P. 159 - 159
Published: Feb. 6, 2025
Background: New strategies for respiratory syncytial virus (RSV) prevention are available and in development, but their acceptance is crucial to effectiveness. Objectives: This systematic review aims summarize current quantitative qualitative evidence regarding knowledge attitudes relating RSV prevention. Methods: Six databases (PubMed, Scopus, APA PsycArticles; PsycInfo; CINAHL Complete; Psychology Behavioral Sciences Collection) two preprint repositories (medRxiv Preprints) were searched up until 23 December 2024 (PROSPERO: CRD42024602351). Results: Sixty-one articles included, focusing on vaccination the elderly adults at risk (n = 10) or pregnant people 24, of which 8 also examined preferences maternal vs. infant immunization) immunization 27, 16 focused palivizumab, with 6 adherence its monthly administration). Eighteen assessed healthcare professionals. Overall, findings showed limited awareness generally positive towards moderate high intentions uptake rates. Protection against disease perceived severity promoted acceptance, whereas concerns about side effects hindered it. Maternal was more acceptable than immunization. Conclusions: Attitudes options favorable. Should become available, may depend characteristics, how they framed presented. These insights highlight importance education grounded decision-making literature, while recognizing likely favorable reception preventive measures across target age-populations.
Language: Английский
Citations
1The Lancet Infectious Diseases, Journal Year: 2024, Volume and Issue: 24(12), P. e747 - e761
Published: Sept. 23, 2024
Language: Английский
Citations
7The Pediatric Infectious Disease Journal, Journal Year: 2025, Volume and Issue: 44(2S), P. S11 - S12
Published: Feb. 1, 2025
New maternal vaccines could reduce infant deaths at and after birth, especially in low- middle-income countries. Work is underway to prepare for new globally, the Maternal Immunization Readiness Network Africa Asia will support in-country preparation several However, impact of only be realized with supportive policy recommendations sufficient financing development immunization platforms.
Language: Английский
Citations
0Published: July 15, 2024
The recently approved maternal vaccination against respiratory syncytial virus (RSV) can reduce its burden among infants. Vaccine hesitancy/resistance undermine the beneficial impact of RSV vaccination. aim this study was to assess willingness pregnant women in Jordan receive and associated determinants. Face-to-face interviews were conducted obstetrics/gynecology clinics during January-February 2024, with convenience sampling. Attitude assessed using previously validated ABCDEF scale. A total 404 participated a mean age 30 years. majority participants showed (n=313, 77.5%), hesitancy 25 (6.2%), resistance 66 (16.3%). Variables that signifi-cantly higher vaccine acceptance multivariate analysis were:
Language: Английский
Citations
3Gates Open Research, Journal Year: 2024, Volume and Issue: 8, P. 94 - 94
Published: Aug. 29, 2024
Language: Английский
Citations
0Gates Open Research, Journal Year: 2024, Volume and Issue: 8, P. 94 - 94
Published: Oct. 21, 2024
Language: Английский
Citations
0